Oxybutynin (chloride) (Standard) is the analytical standard of Oxybutynin (chloride). This product is intended for research and analytical applications. Oxybutynin chloride is an oral active and competitive mAChR antagonist with Kis of 14.3 and 5.55 nM for specific [3H]NMS binding in the mouse bladder and cerebral cortex, respectively. Oxybutynin chloride inhibits vascular Kv channels in […]

Oxybutynin-d5 hydrochloride is deuterated labeled (R)-Oxybutynin hydrochloride (HY-B0267B). (R)-Oxybutynin hydrochloride, a (R)-isomer of Oxybutynin hydrochloride, is an orally active muscarinic receptor antagonist. (R)-Oxybutynin hydrochloride has antimuscarinic, antispasmodic and anticholinergic activity, competitively antagonizes Carbachol-induced contractions. (R)-Oxybutynin hydrochloride can be used for researching incontinence due to neurogenic bladder dysfunction[1][2][3]. (R)-Oxybutynin hydrochloride is a click chemistry reagent, it […]

Oxyclozanide (Standard) is the analytical standard of Oxyclozanide. This product is intended for research and analytical applications. Oxyclozanide is an orally active salicylanilide anthelmintic agent that mainly acts by uncoupling oxidative phosphorylation in flukes. Oxyclozanide shows good anti-adenovirus, anti-biofilm, antifungal, and antibacterial activity[1][2][3].

Oxyfluorfen-d5 is deuterated labeled Oxyfluorfen (HY-119176) Oxyfluorfen is a pre- and post-emergence diphenyl ether herbicide to control annual broad-leaved and grass weeds. Oxyfluorfen is a protoporphyrinogen oxidase inhibitor and inhibits photosynthesis by blocking chlorophyll synthesis.

Oxypurinol-13C,15N2 is 15N and 13C labeled Oxypurinol (HY-19657). Oxipurinol (Oxipurinol), the major active metabolite of Allopurinol, is an inhibitor of xanthine oxidase. Oxipurinol can be used to regulate blood urate levels and treat gout[1].

P-gp inhibitor 20 (compound H27) is a low cytotoxicity P-glycoprotein (P-gp) inhibitor. P-gp inhibitor 20 inhibits the efflux function of P-gp in a dose-dependent manner (without affecting the expression of P-gp), thereby reversing the multidrug resistance (MDR) of MCF-7/ADR cells, with an IC50 value of 46.6 nM. P-gp inhibitor 20 can be used for cancer […]

P-gp inhibitor 21 (Compound 56) is an inhibitor for P-glycoprotein (P-gp) transport, which reverses P-gp-mediated multidrug resistance (MDR) and exhibits antitumor efficacy in mice without significant cytotoxicity[1].

P-gp inhibitor 22 is a P-glycoprotein (P-gp) inhibitor that effectively inhibits P-pg and efflux function. P-gp inhibitor 22 induces apoptosis and accumulation of MCF-7/ADR cells processed in the S phase[1].

p-Iodoclonidine hydrochloride is a partial agonist of α2-adrenergic receptor. p-Iodoclonidine hydrochloride also has minimal agonist activity in inhibiting adenylate cyclase in platelet membranes, and potentiates ADP induced platelet aggregation with an EC50 of 1.5 μM[1].

p-NH2-Bn-DOTAis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. p-NH2-Bn-DOTA can be used for conjugation of peptides and radionuclides.

p-NH2-Bn-DOTA-tetra(t-Bu ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. p-NH2-Bn-DOTA-tetra(t-Bu ester) can be used for conjugation of peptides and radionuclides.

p-NH?-Bn-DTPA (hydrochloride)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. p-NH?-Bn-DTPA (hydrochloride) can be used for conjugation of peptides and radionuclides.

p-NH?-Bn-DTPA-penta (t-Bu ester)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. p-NH?-Bn-DTPA-penta (t-Bu ester) can be used for conjugation of peptides and radionuclides.

p-NH2-Bn-NOTA (hydrochloride hydrate)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. p-NH2-Bn-NOTA (hydrochloride hydrate) can be used for conjugation of peptides and radionuclides.

p-NH2-Bn-oxo-DO3Ais a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. p-NH2-Bn-oxo-DO3A can be used for conjugation of peptides and radionuclides.

p-NH?-Bn-PCTA (hydrochloride)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. p-NH?-Bn-PCTA (hydrochloride) can be used for conjugation of peptides and radionuclides.

p-NH2-CHX-A”-DTPA (hydrochloride hydrate)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. p-NH2-CHX-A”-DTPA (hydrochloride hydrate) can be used for conjugation of peptides and radionuclides.

p-NO2-Bn-Cyclenis a bifunctional chelator (Bifunctional Chelator; BFC), which is a derivative of the macrocyclic ligand dodecane backbone Cyclen. p-NO2-Bn-Cyclen can be used for conjugation of peptides and radionuclides.

p-NO2-Bn-DOTAis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. p-NO2-Bn-DOTA can be used for conjugation of peptides and radionuclides.

p-SCN-Bn-HEHA (hydrochloride)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. p-SCN-Bn-HEHA (hydrochloride) can be used for drug conjugation.

p-SCN-Bn-NOTA (trihydrochloride)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. p-SCN-Bn-NOTA (trihydrochloride) can be used for conjugation of peptides and radionuclides.

p-SCN-Bn-oxo-DO3Ais a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DOTA derivative used for tumor pre-targeting. p-SCN-Bn-oxo-DO3A can be used for conjugation of peptides and radionuclides.

p-SCN-Bn-PCTA (hydrochloride)is a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic DPTA derivative used for tumor pre-targeting. p-SCN-Bn-PCTA (hydrochloride) can be used for conjugation of peptides and radionuclides.

p-Terphenyl is a p-terphenyl that can be isolated from Aspergillus of the genus Thelephora. p-Terphenyl showed significant anti-tumor and anti-metastatic effects in xenograft models of gastric and pancreatic cancer. Derivatives of p-Terphenyl also have anti-inflammatory or anti-proliferative effects[1].

p-Terphenyl is a p-terphenyl that can be isolated from Aspergillus of the genus Thelephora. p-Terphenyl showed significant anti-tumor and anti-metastatic effects in xenograft models of gastric and pancreatic cancer. Derivatives of p-Terphenyl also have anti-inflammatory or anti-proliferative effects[1].

p-Vinylphenyl O-β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside is a phenolic glycoside that can be isolated from the leaves of Viburnum furcatum[1].

P2RX1 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2rx1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx1 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2rx1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2RX2 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2rx2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx2 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2rx2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2RX3 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2rx3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx3 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2rx3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2RX4 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2rx4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx4 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2rx4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2RX5 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RX5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2RX6 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RX6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2RX7 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RX7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

P2rx7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2rx7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.